4-carboxy-3-hydroxyphenylglycine has been researched along with bay36-7620 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, F; Janssen, C; Langlois, X; Lavreysen, H; Lesage, AS; Leysen, JE | 1 |
| Johnson, MP; Kingston, AE; Schkeryantz, JM | 1 |
1 review(s) available for 4-carboxy-3-hydroxyphenylglycine and bay36-7620
| Article | Year |
|---|---|
Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain.
Topics: Analgesics; Animals; Humans; Pain; Peripheral Nervous System Diseases; Receptors, Metabotropic Glutamate | 2007 |
1 other study(ies) available for 4-carboxy-3-hydroxyphenylglycine and bay36-7620
| Article | Year |
|---|---|
[3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists.
Topics: Adamantane; Allosteric Regulation; Animals; Binding Sites; Binding, Competitive; Brain; Cell Line; Cell Membrane; CHO Cells; Chromones; Cricetinae; Humans; Naphthalenes; Pyrans; Quinolines; Quinoxalines; Quisqualic Acid; Radioligand Assay; Rats; Receptors, Metabotropic Glutamate; Transfection; Tritium | 2003 |